Drug profile · INN
diazoxide
DIAZOXIDE
diazoxide (DIAZOXIDE) is a potassium channel, inwardly rectifying, subfamily j, member 11 opener. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — diazoxide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
diazoxide (DIAZOXIDE) is a potassium channel, inwardly rectifying, subfamily j, member 11 opener. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium channel, inwardly rectifying, subfamily J, member 11 opener
Primary target: ATP-sensitive inward rectifier potassium channel 11
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is diazoxide?
diazoxide (DIAZOXIDE) is a potassium channel, inwardly rectifying, subfamily j, member 11 opener. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for diazoxide?
DIAZOXIDE is a marketed brand name for diazoxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diazoxide?
diazoxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.